The Central Dogma: Chemical Logic of Information Flow
A bacterium dividing every twenty minutes must copy three million base pairs almost perfectly. It must transcribe thousands of genes on demand. It must translate each message into a folded, functional protein. All of this uses nothing but non-covalent recognition and a small set of phosphoryl-transfer reactions. The astonishing reliability of heredity traces back to one chemical fact. So does the equally astonishing responsiveness of gene expression to a changing cell. Base pairing between complementary nucleotides is specific enough to serve as a template. Yet it is weak enough to be read, copied, and erased. This happens using ordinary thermal energy and enzyme catalysis. This article is about that chemical fact and its consequences. The Central Dogma, as Francis Crick stated it in 1958 and refined in 1970, is a statement about direction. Specifically, it concerns the direction in which sequence information can flow. It concerns the three great classes of biological polymer: DNA, RNA, and protein. Information can flow DNA→DNA (replication), DNA→RNA (transcription), and RNA→protein (translation). It can also flow RNA→DNA (reverse transcription, in retroviruses) and RNA→RNA (in RNA viruses). What it forbids — and no exception has ever been found — is protein→nucleic acid or protein→protein transfer of sequence information. Once information has been cast into the amino acid sequence of a folded protein, it cannot be read back out. It cannot be used to reconstruct a gene. This is not a mystical rule. It is a direct consequence of the chemistry available at each step. We will dissect that chemistry mechanism by mechanism. The deep reason the dogma holds is templating chemistry. DNA and RNA synthesis are both template-directed. An existing polynucleotide strand is read base by base. Each incoming nucleotide is selected because its Watson–Crick face precisely complements the templating base. This happens before a phosphodiester bond is formed. Protein synthesis is also template-directed, but the template (mRNA) is read through an adaptor — transfer RNA. This uses the same base-pairing chemistry, at one further remove. There is no known chemistry, and no known enzyme, that reads the shape of a folded polypeptide. None can reconstruct from it a corresponding base sequence. The side-chain chemistry of amino acids has no complementary "reader". No enzyme analogous to a polymerase active site scans Watson–Crick edges of proteins. This absence is not a law of physics. It is an empirical absence of a class of enzyme. That absence is the entire chemical basis of the one-way arrow from protein back to nucleic acid. This article builds outward from base-pairing chemistry to the shared logic of the three central reactions. We derive the energetics that make phosphodiester bond formation favorable. We examine the nucleotidyl-transfer mechanism common to every polymerase. We show why fidelity is a kinetic — not just thermodynamic — property of these enzymes. The treatment sets up, without duplicating, the mechanistic detail found in DNA Replication: The Semiconservative Mechanism, Transcription: Overview and RNA Polymerase, and Translation and the Genetic Code: Overview.
- The Central Dogma describes allowed directions of sequence information transfer: DNA→DNA, DNA→RNA, RNA→protein (plus RNA→DNA and RNA→RNA in some viruses), never protein→nucleic acid.
- All nucleic acid synthesis uses the same core reaction: nucleophilic attack of a 3′-OH on the α-phosphate of an incoming NTP/dNTP, releasing pyrophosphate.
- Pyrophosphate hydrolysis (ΔG°′ ≈ −33.5 kJ/mol) is the thermodynamic engine that pulls polymerization forward and makes it effectively irreversible in the cell.
- Fidelity comes from Watson–Crick geometric selection at the templating step, reinforced kinetically by conformational proofreading and, in DNA polymerases, a separate 3′→5′ exonuclease active site.
- Translation adds a layer of chemistry: the genetic code is implemented by aminoacyl-tRNA synthetases, which covalently link amino acids to tRNA adaptors so that codon–anticodon pairing indirectly specifies protein sequence.
- The dogma is a statement about mechanism, not information theory in the abstract — it holds because no enzyme exists that reads protein structure and writes a complementary nucleic acid sequence.
- Key idea: every step of gene expression is templated by Watson–Crick pairing chemistry and driven thermodynamically by phosphate bond hydrolysis; information flows in only the directions that this chemistry can physically execute.
Sequence information moves only along chemical pathways where a template can be read by base-pairing (or codon–anticodon pairing) and copied by a phosphoryl-transfer active site; no enzyme exists that reverses this by reading protein structure back into nucleotide sequence, which is why the dogma's forbidden arrows are forbidden.
Where this lives today
The chemical logic of the Central Dogma underlies essentially every modern biotechnology built on nucleic acids. PCR (polymerase chain reaction) exploits the same nucleotidyl-transfer chemistry described here, using a thermostable DNA polymerase (Taq or Pfu) to exponentially copy a template in vitro; the fidelity trade-offs derived in this article (base pairing vs. proofreading exonuclease activity) directly explain why Pfu polymerase, which carries 3′→5′ proofreading, is preferred over Taq (which lacks it) for cloning applications requiring high sequence accuracy. mRNA vaccines (against SARS-CoV-2 and other pathogens) exploit the DNA→RNA→protein pathway directly: a synthetic mRNA, delivered in a lipid nanoparticle, is translated by the recipient's own ribosomes using exactly the codon-reading, aminoacyl-tRNA-adaptor chemistry described here, with no DNA intermediate required in the cell. Reverse transcriptase, discovered as confirmation of an RNA→DNA channel, is now the workhorse enzyme of RT-PCR diagnostics (including COVID-19 testing) and of retroviral gene therapy vectors, which co-opt HIV's own reverse-transcription chemistry to integrate therapeutic genes into a patient genome. CRISPR-Cas9 gene editing depends on RNA-guided, base-pairing-directed DNA recognition — a direct descendant of the same Watson–Crick templating logic that makes replication and transcription possible. Antibiotics such as rifampicin (which blocks bacterial RNA polymerase's nucleotidyl-transfer active site) and nucleoside-analog antivirals such as acyclovir, AZT, and remdesivir (which are incorporated by viral polymerases and then stall the chain because they lack a proper 3′-OH nucleophile) are rationally designed drugs that exploit the precise mechanism worked out in the derivations above, deliberately sabotaging the nucleotidyl-transfer step that both DNA Replication: The Semiconservative Mechanism and Transcription: Overview and RNA Polymerase depend on.
Ask the tutor: How does the two-metal-ion mechanism differ mechanistically between DNA polymerase, RNA polymerase, and reverse transcriptase?
The physical picture — thorough prose
Consider the three macromolecular alphabets side by side. DNA and RNA are built from four nucleotides differentiated by a purine or pyrimidine base attached to a sugar-phosphate backbone; the chemical logic of replication and transcription is that each base presents a unique hydrogen-bonding face — the Watson–Crick edge — that pairs with one, and only one, complementary base with high fidelity: A with T (or U), G with C. Proteins are built from twenty amino acids differentiated by side chains with no shared "recognition edge" and no complementary partner chemistry; a protein's sequence is read out during folding into three-dimensional shape, not into a linear code that another molecule can pair against. This structural asymmetry between the nucleic acid alphabet (paired, linear, self-complementary) and the protein alphabet (functional, three-dimensional, non-complementary) is the root cause of the dogma's directionality. Template-directed synthesis works because the templating strand pre-organizes the incoming monomer. In DNA replication, the enzyme DNA polymerase holds a single-stranded template in its active site; the correct incoming deoxynucleoside triphosphate (dNTP) forms Watson–Crick hydrogen bonds with the templating base, and only a correctly paired, correctly geometried dNTP triggers the conformational closure of the polymerase "fingers" domain that aligns the reactive groups for catalysis. The reaction is a nucleotidyl transfer: the 3′-hydroxyl of the growing primer strand executes an in-line nucleophilic attack on the α-phosphorus of the incoming dNTP, displacing pyrophosphate (PPi) and forming a new phosphodiester bond. RNA polymerases in transcription and DNA polymerases in replication use chemically identical two-metal-ion catalysis at this step, differing mainly in which sugar (ribose vs. deoxyribose) and which base-pairing partner (U vs. T) is used. Translation is templated too, but at one remove. The mRNA is read three nucleotides (a codon) at a time; the direct reader of the codon is not the amino acid itself but a transfer RNA (tRNA) bearing a complementary anticodon and, on its 3′ end, a covalently attached amino acid. The linkage between amino acid identity and anticodon sequence is established earlier, by an aminoacyl-tRNA synthetase, which recognizes both the amino acid and the correct tRNA and joins them using ATP. Once that ester bond is formed, the ribosome no longer needs to "know" what the amino acid is — it trusts the codon–anticodon pairing implicitly, an idea captured in Crick's own 1958 "adaptor hypothesis." This indirection is precisely what makes translation irreversible as an information channel: the ribosome reads nucleic acid sequence and writes peptide bonds, but nothing in ribosomal chemistry reads a peptide bond and regenerates a codon.
The core ideas — governing relationships
The overall polymerization reaction, for both DNA and RNA synthesis, is
where: is the growing nucleic acid chain of residues, NTP (or dNTP) is the incoming nucleoside triphosphate selected by Watson–Crick pairing to the template, and PPi is inorganic pyrophosphate, the two-phosphate leaving group. The standard free energy of this step is close to thermoneutral by itself; what drives the overall process is the follow-up hydrolysis of pyrophosphate by cellular pyrophosphatase:
where: Pi is inorganic orthophosphate and ΔG°′ is the standard free energy change at pH 7, 25 °C, standard biochemical conditions. Because this hydrolysis is rapid and essentially irreversible in vivo, the net reaction for adding one nucleotide,
has a substantially negative ΔG°′ overall, making polymer elongation thermodynamically committed in the forward direction — a textbook example of coupling a reversible step to an irreversible one to achieve unidirectionality, the same design principle you meet in Base pairing-driven recognition steps throughout the cell. Fidelity of template copying is best expressed as a discrimination ratio between correct and incorrect nucleotide incorporation, arising from the ratio of catalytic efficiencies:
where: is the maximal turnover rate for phosphodiester bond formation once dNTP is bound, and is the Michaelis constant reflecting both binding affinity and the rate of the conformational closure step; is the fold-discrimination against a mismatched nucleotide. For a high-fidelity replicative polymerase, from base selection alone is typically –; proofreading by a 3′→5′ exonuclease multiplies this by a further –, giving overall replication error rates near – per base pair, matching measured mutation rates in organisms with proofreading polymerases.
Two derivations
Goal. Show quantitatively that coupling nucleotide addition to pyrophosphate hydrolysis shifts the equilibrium of chain elongation overwhelmingly toward the product side, even though the bare phosphodiester-bond-forming step is close to thermoneutral.
Step 1 — the bare nucleotidyl transfer step. Consider first only
Measured ΔG°′ for phosphodiester bond formation from an NTP is small, typically in the range of 0 to +8 kJ/mol depending on sequence context (comparable in magnitude to the phosphoanhydride bond broken in the NTP). Take a representative value ΔG°′₁ ≈ +6.0 kJ/mol for this isolated step. The equilibrium constant for this step alone is
which favors the reverse reaction (pyrophosphorolysis) roughly 11-fold — by itself, this reaction would not reliably build long polymers.
Step 2 — couple to pyrophosphatase. The cell maintains an essentially irreversible pyrophosphatase reaction:
Adding the two reactions (thermodynamic state functions are additive along a reaction path) gives the coupled overall reaction
with
Step 3 — new equilibrium constant.
The equilibrium constant swings from favoring hydrolysis of the polymer by a factor of ~11 to favoring polymer synthesis by a factor of ~66,000 — a shift of roughly -fold — purely because pyrophosphate is removed from the equilibrium by hydrolysis before it can drive the reaction backward. In the cell, pyrophosphatase keeps [PPi] low, and Le Chatelier's principle (via mass action, not a change in the intrinsic bond chemistry) locks the reaction forward. This is why every polymerase — DNA, RNA, and even the non-templated poly(A) polymerase — releases PPi rather than Pi, and why cells universally express pyrophosphatases at high activity near sites of nucleic acid synthesis.
Limiting case. If pyrophosphatase activity were absent and PPi accumulated to a concentration high enough that reaction quotient equaled , net synthesis would stop entirely; this is observed experimentally when PPi is added in vitro to polymerase reactions without a pyrophosphatase-coupled assay, causing measurable reversal (pyrophosphorolysis) of the reaction — a classic control used to demonstrate microscopic reversibility of the polymerase active site.
Go deeper · Derivation B · 2 minFidelity as a kinetic branching problem: why Watson–Crick geometry alone is not enough
Goal. Derive how the ratio of forward rates for correct versus incorrect nucleotide incorporation combines multiplicatively across sequential kinetic checkpoints (binding/pairing, conformational closure, chemistry, and proofreading) to give the very low observed error rates of replicative polymerases.
Step 1 — single-step discrimination from base pairing alone. The free energy difference between a correct Watson–Crick pair (e.g., G·C, three hydrogen bonds plus optimal stacking) and a mismatch (e.g., G·T, requiring geometric distortion) is modest, typically ΔΔG ≈ 3–6 kJ/mol per mismatch in a helix. Using ΔΔG = 5.0 kJ/mol as a representative value at 310 K (37 °C, physiological temperature):
This is a strikingly small number — base pairing thermodynamics alone would give error rates near , wildly higher than observed replication fidelity. Something else must be doing most of the discriminating.
Step 2 — kinetic proofreading via an induced-fit conformational step. Polymerases do not simply bind dNTP and react; correct pairing triggers a large-scale closure of the "fingers" subdomain that is itself slow and can revert if pairing is wrong. This inserts an additional kinetic checkpoint before the irreversible chemical step. If the closure step for a correctly paired dNTP proceeds forward with rate much faster than it reverts (rate ), while a mismatched dNTP's closure step reverts much faster than it proceeds, the branching ratio compounds:
where: is the extra discrimination from the fingers-closing/opening kinetic competition (typically 10²–10³ for high-fidelity polymerases), and is discrimination arising because a mispaired 3′-OH is geometrically misaligned for in-line attack on Pα, slowing itself by another factor of 10–100. Multiplying representative values, , consistent with the measured overall fidelity of E. coli DNA polymerase III core (holoenzyme, without proofreading) of roughly –.
Step 3 — proofreading exonuclease as an independent kinetic filter. A separate active site (the 3′→5′ exonuclease domain, spatially distinct from the polymerase site) excises a newly added nucleotide if it is mismatched, because a mismatched terminus frays and partitions preferentially into the exonuclease site rather than being extended. This proofreading step is kinetically independent of the initial selection step (different active site, different rate-limiting conformational change), so its discrimination factor multiplies rather than adds:
With – (a typical proofreading efficiency), overall fidelity reaches
corresponding to an error rate near per base incorporated by the polymerase alone — further reduced in vivo by mismatch repair to the observed genome-wide mutation rate of about – per base pair per generation in bacteria.
Limiting case. If the conformational closure step were fast and freely reversible in both directions regardless of pairing correctness (i.e., ), fidelity would collapse to , i.e., an error rate near — comparable to what is observed for polymerases that entirely lack an induced-fit checkpoint (some low-fidelity translesion polymerases), confirming that the induced-fit step, not base-pairing thermodynamics, supplies most of the discriminatory power.
Worked examples
Example 1 — Foundational: converting a coding-strand DNA sequence into an mRNA and reading the reading frame. A coding (non-template, sense) strand of DNA reads, 5′→3′:
The RNA polymerase reads the complementary template strand 3′→5′ and synthesizes RNA 5′→3′ using U in place of T; because the template strand is complementary and antiparallel to the coding strand, the mRNA produced is identical to the coding strand except U replaces T:
Reading in codons: AUG (start, Met), GCU (Ala), UGG (Trp), UAA (stop). The peptide product before removal of the initiator methionine is Met-Ala-Trp (3 residues), then translation terminates because UAA is a stop codon recognized not by a tRNA but by a release factor, which triggers hydrolysis of the ester bond linking the final peptide to the P-site tRNA — a hydrolysis, not a nucleotidyl-transfer step, terminating the chain. This example fixes the basic vocabulary: coding strand ≈ mRNA sequence (with T→U), template strand is read in the 3′→5′ direction, and every synthesis step (DNA, RNA, protein) proceeds 5′→3′ (or N-terminus→C-terminus for protein).
Example 2 — Applied: calculating replication fidelity contribution from a measured mismatch discrimination and comparing to a known polymerase's in vivo mutation rate. Suppose steady-state kinetic assays on a hypothetical DNA polymerase give:
The base-selection fidelity is
This corresponds to an error probability per incorporation event of
If this polymerase also possesses a proofreading exonuclease with an independently measured efficiency factor of 250 (i.e., 1 in 250 initially mis-incorporated bases survives excision), the combined error rate becomes
For a genome of base pairs (the size of the E. coli chromosome), the expected number of uncorrected replication errors per genome per round is
meaning on average roughly one error survives every 3–4 replication cycles from polymerase fidelity alone, before mismatch repair acts — consistent in order of magnitude with the measured contribution of DNA polymerase III to E. coli's overall mutation rate, with post-replicative mismatch repair further lowering the final rate by another 100–1000-fold.
Example 3 — Exam/competition level: energetic accounting across all three steps of the dogma for synthesizing one tripeptide from an mRNA template, and identifying which single reaction is chemically irreversible in the cell. Consider the synthesis of the tripeptide Met-Ala-Trp described in Example 1, starting from a naked DNA template and finishing at a folded, functional 3-residue peptide (illustratively — real proteins are far longer, but the accounting scales linearly). Transcription cost: synthesizing a 12-nucleotide mRNA (matching the 12-base coding sequence above) requires forming 11 new phosphodiester bonds (the first nucleotide is not linked via a new bond to a preceding residue). Using the coupled ΔG°′ ≈ −27.5 kJ/mol per bond from Derivation 1 (via pyrophosphate hydrolysis):
Aminoacylation cost: each amino acid is activated by its cognate aminoacyl-tRNA synthetase, consuming one ATP → AMP + PPi per amino acid (a two-step reaction: amino acid + ATP → aminoacyl-AMP + PPi, then aminoacyl-AMP + tRNA → aminoacyl-tRNA + AMP). The PPi released is again hydrolyzed, pulling activation forward with an overall ΔG°′ per amino acid comparable in magnitude to ATP hydrolysis to AMP + PPi, roughly −45.6 kJ/mol (using ΔG°′ for ATP→AMP+PPi ≈ −45.6 kJ/mol, since this bond cleavage releases the terminal pyrophosphate directly). For 3 amino acids:
Peptide bond formation on the ribosome: forming each peptide bond via the ribosome's peptidyl transferase center costs one additional GTP hydrolysis for EF-Tu-mediated delivery (~−30.5 kJ/mol) plus one GTP for EF-G-mediated translocation (~−30.5 kJ/mol) per elongation cycle, in addition to the intrinsically near-thermoneutral peptide-bond-forming step itself (ΔG°′ ≈ 0 to −20 kJ/mol per bond, since ribosomal catalysis exploits substrate positioning rather than large intrinsic ΔG). For 2 peptide bonds formed (tripeptide has 2 bonds) plus initiation (1 GTP for IF2):
Total energetic cost, illustrative:
The exam-level point: every one of these numbers is negative and each stage is driven by hydrolysis of a phosphoanhydride bond (PPi or GTP), yet only one class of reaction in this whole scheme has no known reverse enzymatic pathway operating in normal cellular metabolism — the transfer of information from the folded tripeptide back into a nucleic acid sequence. Every chemical bond formed here (phosphodiester bonds, ester/amide linkages in aminoacyl-tRNA, and peptide bonds) is thermodynamically capable of hydrolysis, and cells do possess hydrolases for essentially all of them (nucleases, esterases, proteases) — but hydrolyzing a peptide bond releases free amino acids, not a sequence-encoding intermediate that could be read by a polymerase. The chemical irreversibility that matters for the Central Dogma is therefore not thermodynamic (all these bonds could in principle be hydrolyzed and reformed) but informational: no enzyme couples the three-dimensional information in folded protein structure to nucleotide sequence selection, so the arrow protein→nucleic acid has no chemical channel at all, regardless of the sign of any ΔG.
Limiting cases, scope & common traps
| Scenario | What happens | Why |
|---|---|---|
| Retrovirus infection (e.g., HIV) | RNA→DNA information flow occurs | Reverse transcriptase is a real, characterized polymerase using RNA as template and dNTPs as substrate; this is fully consistent with the dogma as Crick stated it (RNA→DNA was always an allowed arrow, just not observed until 1970) |
| RNA virus replication (e.g., poliovirus, SARS-CoV-2) | RNA→RNA information flow occurs | RNA-dependent RNA polymerase performs the same nucleotidyl-transfer chemistry, template strand is RNA, product is RNA |
| Prion propagation | A misfolded protein converts other protein molecules to its conformation | This is conformational templating, not sequence information transfer — no new amino acid sequence is created or read; the primary structure is identical in both conformers, so this does not violate the dogma |
| Reverse translation ("protein→RNA") | Never observed | No enzyme reads a folded polypeptide backbone/side-chain pattern and selects complementary nucleotides; there is no known chemical mechanism, not merely an unobserved one |
| Epigenetic inheritance (DNA methylation, histone marks) | Heritable phenotypic information without DNA sequence change | Operates alongside the dogma, modulating expression, not altering the direction of sequence information flow itself |
| Pyrophosphorolysis in vitro | Polymerase runs in reverse, degrading nucleic acid and regenerating NTP | Confirms microscopic reversibility of the chemical step itself; happens only when PPi is artificially allowed to accumulate, i.e., outside normal cellular conditions where pyrophosphatase keeps [PPi] low |
The chemist behind it
Francis Harry Compton Crick trained first as a physicist, working on magnetic mines during the Second World War, before turning to biology in his thirties — a career pivot he attributed to a growing conviction that the boundary between the living and non-living world, and the nature of heredity, were the deepest unsolved problems accessible to a physicist's tools. After the 1953 double-helix paper with James Watson (built on Rosalind Franklin's X-ray diffraction data), Crick turned his attention to the coding problem: given that DNA sequence somehow specified protein sequence, what physical mechanism could perform the translation? His 1958 paper "On Protein Synthesis" introduced both the "Sequence Hypothesis" (that a nucleic acid's specificity resides entirely in its base sequence, and this sequence is a code for the amino acid sequence of some protein) and the "Central Dogma," alongside the theoretically predicted — and later experimentally confirmed by Hoagland, Zamecnik, and others — adaptor molecule we now call tRNA. Crick had reasoned, entirely from chemical first principles, that amino acids could not plausibly recognize codons directly (there is no obvious chemical complementarity between an amino acid side chain and a trinucleotide), so some adaptor molecule bearing both an amino-acid-attachment site and a codon-reading anticodon had to exist; this is among the most celebrated pieces of purely deductive reasoning in twentieth-century biochemistry, confirmed by direct biochemical isolation of tRNA within a few years.
Origins · 1 minFrancis Harry Compton Crick and how this was discovered
Trained in physics, redirected by the "gene problem" after WWII; co-discovered the double helix structure of DNA with James Watson in 1953 using Rosalind Franklin's diffraction data; formulated the Sequence Hypothesis and Central Dogma of molecular biology in 1958, correctly predicting the existence of adaptor molecules (tRNA) before their biochemical isolation; shared the 1962 Nobel Prize in Physiology or Medicine with Watson and Maurice Wilkins.
Does reverse transcription in HIV violate the Central Dogma?
No. Crick's original 1958/1970 formulation only forbids information transfer from protein into nucleic acid; it explicitly permits nucleic-acid-to-nucleic-acid transfers in any direction, including RNA→DNA. Reverse transcriptase, discovered in 1970 by Temin and Baltimore, performs template-directed DNA synthesis using an RNA template and the same nucleotidyl-transfer chemistry (3′-OH attacking Pα, releasing PPi) used by all polymerases. This was, in fact, a channel Crick had anticipated as chemically plausible, since it involves reading a nucleic acid template with Watson–Crick pairing chemistry — exactly the kind of reaction the dogma's allowed arrows describe. It is a confirmation of the dogma's scope, not an exception to it.
Why can't ribosomes run in reverse and turn a protein back into an mRNA sequence?
Because the ribosome's peptidyl transferase center catalyzes peptide bond formation using the amino group of an incoming aminoacyl-tRNA attacking the ester-linked carbonyl of the peptidyl-tRNA in the P site — a reaction whose chemistry depends on codon–anticodon pairing having already selected the correct aminoacyl-tRNA before the ribosome ever "sees" the amino acid's identity chemically. Once the peptide bond forms, all information about which tRNA (and hence which codon) supplied that residue is lost; the amide bond looks identical regardless of which codon specified it, since several different codons can encode the same amino acid (degeneracy of the genetic code) and, more fundamentally, peptide bond geometry carries no memory of anticodon sequence. There is no known active site anywhere in biology that reads a peptide bond's local chemistry and infers a base triplet.
What did Crick mean by the "Sequence Hypothesis," and how does it relate to the dogma?
The Sequence Hypothesis states that the specificity of a nucleic acid is expressed solely through its sequence of bases, and that this sequence constitutes a code for the amino acid sequence of a particular protein. It is a statement about what information nucleic acids carry and how it is encoded (a linear, digital code read three bases at a time). The Central Dogma is a separate, complementary statement about the direction in which that encoded information is allowed to flow between polymer classes. Together they form the conceptual foundation of molecular biology: sequence carries information (Sequence Hypothesis), and information flows only along certain chemically realizable channels (Central Dogma).
How does aminoacyl-tRNA synthetase "know" which amino acid belongs with which anticodon?
Each of the twenty aminoacyl-tRNA synthetases is a distinct enzyme (or enzyme family) that recognizes both a specific amino acid and the correct set of tRNA molecules bearing the corresponding anticodon(s), using recognition elements that include the anticodon itself, the acceptor stem sequence, and sometimes other tRNA body features (collectively the "identity elements" or second genetic code). The synthetase first activates the amino acid using ATP to form an aminoacyl-adenylate (aminoacyl-AMP) intermediate, releasing PPi, then transfers the aminoacyl group onto the 2′- or 3′-OH of the tRNA's terminal adenosine, releasing AMP. Many synthetases also proofread this step, hydrolyzing incorrectly charged tRNAs, achieving fidelities in the range of 10⁴–10⁵ that are essential since the ribosome itself cannot check amino acid identity once charging is complete.
Is DNA methylation or histone modification a violation of the dogma since it's "information" not stored in base sequence?
No, because epigenetic marks do not transfer sequence information from protein to nucleic acid; they are chemical modifications (methyl groups on cytosine, acetyl/methyl groups on histone tails) added by enzymes that read existing chromatin states and write new covalent marks using small-molecule cofactors (SAM for methylation, acetyl-CoA for acetylation) — not by reading a protein's amino acid sequence and encoding it into DNA bases. Epigenetic inheritance modulates when and how much a gene is expressed; it does not create new base sequence information and does not reverse the arrow from protein to nucleic acid. It operates as a regulatory layer alongside, not through, the central information-flow chemistry.
Why is the genetic code read as non-overlapping triplets rather than, say, pairs or quadruplets?
With four bases, doublets could specify only 4² = 16 combinations — insufficient to uniquely encode 20 amino acids — while triplets give 4³ = 64 combinations, more than enough, with room for redundancy (multiple codons per amino acid) and stop signals. This was established experimentally by Crick, Barnett, Brenner, and Watts-Tobin's 1961 frameshift mutation experiments in bacteriophage T4, which showed that insertions or deletions of one or two bases disrupted the reading frame catastrophically, while insertions/deletions of exactly three bases largely restored function downstream — direct genetic proof that the code is read in non-overlapping groups of three, confirmed shortly afterward by Nirenberg and Khorana's biochemical codon assignments.
What experimentally would count as a genuine violation of the Central Dogma?
A demonstrated enzymatic mechanism in which the amino acid sequence (or three-dimensional fold) of a protein is used as a template to direct the synthesis of a nucleic acid with a corresponding, non-random base sequence — i.e., an enzyme that "reads" protein structure and "writes" complementary genetic information. No such mechanism has ever been observed in over sixty years of intense scrutiny across all three domains of life and all known viruses, despite deliberate searches (partly motivated by early, incorrect ideas like Lamarckian inheritance of acquired traits). Its absence is now considered one of the most robust empirical generalizations in all of biology.